Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Biphenotypic, Acute × decitabine and cedazuridine drug combination × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 8 Myelodysplastic Syndromes 5 Myeloproliferative Disorders 3 Myelodysplastic-Myeloproliferative Diseases 2 Leukemia, Myelomonocytic, Chronic 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Hodgkin Disease 1 GATA2 Deficiency 1 Carcinoma, Merkel Cell 1 Anemia, Refractory, with Excess of Blasts 1 Allogeneic Stem Cell Transplantation 1 Accelerated Phase Myeloproliferative Neoplasm 1

Interventions

Cytarabine 7 Cyclophosphamide 7 venetoclax 5 fludarabine 5 Mycophenolic Acid 5 Methotrexate 5 Granulocyte Colony-Stimulating Factor 5 Filgrastim 5 Whole-Body Irradiation 4 Vincristine 4 Stem Cell Transplantation 4 Specimen Handling 4 Hydrocortisone 4 Dexamethasone 4 Azacitidine 4 revumenib 3 fludarabine phosphate 3 dexamethasone acetate 3 dexamethasone 21-phosphate 3 calaspargase pegol 3 Mesna 3 Leucovorin 3 Doxorubicin 3 Daunorubicin 3 Calcium Dobesilate 3 Bone Marrow Transplantation 3 merphos 2 exifone 2 azathiopurine 2 auricularum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡